
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (03): 372-379.DOI: 10.12114/j.issn.1007-9572.2022.0327
• Review & Perspectives • Previous Articles Next Articles
Received:2022-05-06
Revised:2022-07-22
Published:2023-01-20
Online:2022-06-27
Contact:
YU Xueqing
About author:
通讯作者:
余学庆
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0327
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
李炯. 特发性肺纤维化病情评估和预后生物标志物的研究进展[J]. 重庆医学,2017,46(25):3591-3594. DOI:10.3969/j.issn.1671-8348.2017.25.045.
|
| [7] |
袁殷茹,张敏. 特发性肺纤维化预后相关生物标志物的研究进展[J]. 中国医药导报,2017,14(5):31-34.
|
| [8] |
王慧选,徐敏纹,鹿莉,等. 间质性肺病小鼠循环纤维细胞与血清KL-6的相关性[J]. 中国老年学杂志,2019,39(21):5336-5339. DOI:10.3969/j.issn.1005-9202.2019.21.060.
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
周益民,杜晓敏. 肺表面活性物质SP-A和SP-D免疫调节机制研究进展[J]. 中国预防兽医学报,2020,42(12):1296-1301. DOI:10.3969/j.issn.1008-0589.202005020.
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
廖明星,潘瑞琪,艾承锦,等. 肺纤维化血清KL-6、TGF-β、CXCL13水平与病变程度的关系及其联合预测价值[J]. 医学研究生学报,2021,34(1):62-67. DOI:10.16571/j.cnki.1008-8199.2021.01.012.
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
张致苍,雷尚昆. 血清LTBP2作为特发性肺纤维化患者预后标志物的研究[J]. 中华肺部疾病杂志(电子版),2019,12(6):733-737. DOI:10.3877/cma.j.issn.1674-6902.2019.06.013.
|
| [40] |
丁丽丽,蔡暖暖,陈丽瑾,等. 血清HMGB1、LTBP2、AGE/RAGEs水平与特发性肺纤维化患者肺功能及预后的关系[J]. 疑难病杂志,2021,20(5):470-475. DOI:10.3969/j.issn.1671-6450.2021.05.008.
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
白艳玲,朱海燕,孙启玉,等. 血管生成素对特发性肺纤维化预后的预测价值[J]. 中华危重病急救医学,2017,29(9):789-793. DOI:10.3760/cma.j.issn.2095-4352.2017.09.005.
|
| [54] |
|
| [55] |
|
| [56] |
宋永娜,王林纳,翟建霞,等. MUC5B启动子rs35705950、rs868903基因多态性与特发性肺纤维化的相关性研究[J]. 临床肺科杂志,2021,26(5):682-686. DOI:10.3969/j.issn.1009-6663.2021.05.008.
|
| [57] |
|
| [58] |
郭璐,钟振东,刘晓姝,等. MUC5B和TOLLIP基因多态性对特发性肺纤维化患者预后评估的临床研究[J]. 中国呼吸与危重监护杂志,2019,18(6):543-548. DOI:10.7507/1671-6205.201811081.
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
陈存荣,杨婷,许志辉,等. 肺部微生物组成与特发性肺纤维化生存率相关性研究[J]. 中国微生态学杂志,2018,30(12):1444-1447. DOI:10.13381/j.cnki.cjm.201812018.
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [1] | ZENG Ling, XIE Leyun, YU Renhe, SONG Lin, ZENG Saizhen. Age-stratified Clinical Characteristics and Risk Factors for Lobar Pneumonia in Children with Mycoplasma Pneumoniae Pneumonia [J]. Chinese General Practice, 2026, 29(32): 4752-4758. |
| [2] | LI Jing, LIU Ziqi, QIAN Li, YAO Ruiqin. Research Progress on the Role of the Microbiota-gut-brain Axis in Epilepsy [J]. Chinese General Practice, 2026, 29(32): 4821-4826. |
| [3] | WANG Shiyi, FAN Xiaojing, SI Yafei, ZHOU Zhongliang. Advances in Key Measurement Techniques for the Intrinsic Capacity of Elderly in the Context of Healthy Aging [J]. Chinese General Practice, 2026, 29(31): 4662-4666. |
| [4] | ZHAO Jiayi, FAN Jian, YU Dehua. The Current Situation, Challenges, and Coping Strategies of Preserving Ratio Impaired Spirometry [J]. Chinese General Practice, 2026, 29(30): 4366-4371. |
| [5] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [6] | LI Xiling, ZHANG Fan, YANG Xinyue, YANG Heng. Application of Exercise Snacks in Chronic Disease Management: a Scoping Review [J]. Chinese General Practice, 2026, 29(30): 4472-4479. |
| [7] | CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong. Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review [J]. Chinese General Practice, 2026, 29(29): 4200-4210. |
| [8] | ZHANG Tianyu, CHEN Fei, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Significance of Elevated Levels of Leukocyte Immunoglobulin-like Receptor B1, CD36, and Lymphatic Enhancer Factor 1 in Patients with Myeloma [J]. Chinese General Practice, 2026, 29(29): 4272-4280. |
| [9] | LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu. Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia [J]. Chinese General Practice, 2026, 29(29): 4248-4257. |
| [10] | XIE Xiaoyun, LIU Chenxi, LIU Yushu, ZHOU Yihan. Artificial Intelligence Research Practices in Primary Healthcare Institutions in China and the Potential Issue of Data Poverty: a Scoping Review [J]. Chinese General Practice, 2026, 29(28): 4067-4077. |
| [11] | FENG Yachen, LIU Lewei, XUE Jinyue, SUN Xianlin, LIU Huanzhong. Research Progress of Wearable Technology in the Diagnosis and Treatment of Mental Disorders [J]. Chinese General Practice, 2026, 29(27): 4016-4025. |
| [12] | YAN Yi, JIANG Yu, CHEN Bi, ZHANG Cantang, WANG Jing. Study on the Predictive Value of a Multi-parameter Model Based on Lymphocyte Count for the Prognosis of Patients with Acute Exacerbation of Interstitial Lung Disease Complicated with Pulmonary Infection [J]. Chinese General Practice, 2026, 29(26): 3760-3766. |
| [13] | CHENG Guocang, JIA Yuanyuan, ZHAO Tingting, QI Ruixin, NIAN Miaomiao, CHEN Juan. Nrp1 Negatively Regulates PI3K/AKT Pathway to Inhibit the Activation of Lung Fibroblasts and Its Role in Mouse Pulmonary Fibrosis [J]. Chinese General Practice, 2026, 29(26): 3788-3797. |
| [14] | ZHAO Sinan, LIN Shan, KANG Xi, WANG Chunyan, WANG Shunxiang. Impact of Immune Inhibitory Factors Programmed Cell Death Ligand 1 and T Cell Immunoglobulin Mucin-3 on the Prognosis of Hepatocellular Carcinoma Patients [J]. Chinese General Practice, 2026, 29(24): 3461-3465. |
| [15] | WU Liyun, SUN Huajing, GU Yiqing, MEI Ziqi, JIN Shengji, ZHANG Suju, ZHU Yun, ZHANG Yao, LI Qin, LIU Xiaomiao, WANG Qing, BAI Yamei, XU Guihua. Application of Digital-intelligent Technology in Electrocardiographic Monitoring for Acute Myocardial Infarction: a Scoping Review [J]. Chinese General Practice, 2026, 29(24): 3545-3552. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||